|
|
|
|
| LEADER |
03469nam a2200361 u 4500 |
| 001 |
EB001840227 |
| 003 |
EBX01000000000000001004216 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
180702 r ||| eng |
| 130 |
0 |
|
|a Type 1 diabetes in adults (National Clinical Guideline Centre for Acute and Chronic Conditions (Great Britain))
|
| 245 |
0 |
0 |
|a Type 1 diabetes in adults
|h Elektronische Ressource
|b diagnosis and management : 2015 update
|c National Clinical Guideline Centre ; commissioned by the National Institute for Health and Care Excellence
|
| 246 |
3 |
1 |
|a Type one diabetes in adults
|
| 250 |
|
|
|a Final, August 2015
|
| 260 |
|
|
|a [London]
|b National Clinical Guideline Centre
|c August 2015, 2015
|
| 300 |
|
|
|a 1 PDF file (613 pages)
|b illustrations
|
| 505 |
0 |
|
|a Includes bibliographical references
|
| 653 |
|
|
|a United Kingdom
|
| 653 |
|
|
|a Diabetes Mellitus, Type 1 / therapy
|
| 653 |
|
|
|a Evidence-Based Medicine
|
| 653 |
|
|
|a Diabetes Mellitus, Type 1 / complications
|
| 653 |
|
|
|a Treatment Outcome
|
| 653 |
|
|
|a Diabetes Mellitus, Type 1 / diagnosis
|
| 710 |
2 |
|
|a National Clinical Guideline Centre for Acute and Chronic Conditions (Great Britain)
|
| 710 |
2 |
|
|a National Institute for Health and Care Excellence (Great Britain)
|
| 740 |
0 |
2 |
|a Type 1 diabetes in adults
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 490 |
0 |
|
|a Clinical guidelines : methods, evidence and recommendations
|
| 500 |
|
|
|a "This is a partial update of 'Type 1 diabetes : diagnosis and management of type 1 diabetes in children, young people and adults', NICE clinical guideline CG15 (2004). See section 3.4.1 for details of which sections were updated." --PDF pages 19-20
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK315808
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 082 |
0 |
|
|a 610
|
| 520 |
|
|
|a Type 1 diabetes affects over 370,000 adults in the UK, representing approximately 10% of adults diagnosed with diabetes. Given the complexity of its treatment regimens, successful outcomes depend, perhaps more than with any other long-term condition, on full engagement of the adult with type 1 diabetes in life-long day-by-day self-management. In order to support this, the health service needs to provide informed, expert support, education and training as well as a range of other more conventional biomedical services and interventionsfor the prevention and management of long term complications and disability. The number of adults with type 1 diabetes means that, while the condition is certainly not rare, it is not common enough to provide and maintain all the necessary skills in its management for all healthcare professionals who will deal with it. The aim of this guideline is, therefore, to provide evidence-based, practical advice on the steps necessary to support adults with type 1 diabetes to live full, largely unrestricted, lives and avoid the acute and long-term complications of both the disease and of its treatment. NICE last produced such a guideline in 2004. The present guideline is an update of many sections of that guideline, focusing on areas where new knowledge and new treatment opportunities have arisen in the last decade. There have been many such developments, resulting in improving outcomes for adults with type 1 diabetes, but also presenting more challenges in the diversity and complexity of the tools they now have to achieve these outcomes
|